Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Tewfik Miloud, Régis Josien et al.|The Lancet|2020Cited by 445